{"id":1672,"date":"2020-12-14T12:20:23","date_gmt":"2020-12-14T11:20:23","guid":{"rendered":"https:\/\/arcadia.denkanross.de\/?page_id=1672"},"modified":"2020-12-16T16:41:34","modified_gmt":"2020-12-16T15:41:34","slug":"insulin-potentiated-therapy-ipt","status":"publish","type":"page","link":"https:\/\/arcadia.denkanross.de\/en\/cancer-therapies\/insulin-potentiated-therapy-ipt\/","title":{"rendered":"Insulin-potentiated therapy (IPT)"},"content":{"rendered":"\n
\n

Insulin-potentiated therapy for cancer<\/h2>\n\n\n\n

Insulin-potentiated therapy (IPT) is used for the treatment of cancer and also other inflammatory diseases, such as infectious diseases, to increase the main effect of the drugs and minimize side effects. By adding insulin, the drug dose can be reduced by improving tissue uptake, while at the same time the desired effect is enhanced or “potentiated”.<\/p>\n\n\n\n

Over the past 85 years, insulin potentiated therapy (IPT) has established itself as a convincing treatment option. In cancer therapy, IPT is used as a low side effect supplement or even as an alternative to chemotherapy. Cancer cells or chronically infected tissue (e.g. in Lyme disease) are treated specifically, with minimal undesirable side effects. At Arcadia Praxisklinik, we have been successfully using insulin-potentiated therapy for several years.<\/p>\n<\/div><\/div>\n\n\n\n

\n

Cancer loves sugar: IPT reduces the energy supply of the cancer cell<\/h3>\n\n\n\n

The insulin-potentiated therapy is based on the fact that cancer cells have an increased need for sugar. If the hormone insulin is administered in small quantities, the blood sugar level is lowered in a targeted and controlled manner. During the induced hypoglycemia, the active substance (e.g. the chemotherapeutic agent) is administered in an adjusted lower dose. At Arcadia Praxisklinik we use this principle and work with many years of experience in cancer treatment with IPT.<\/p>\n<\/div><\/div>\n\n\n\n

\n
\n
\n

Certified IPT doctors: Exclusive knowledge for cancer treatment<\/h3>\n\n\n\n
\"\"
Dr. med. Henning Saupe, Medical Director<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

IPT was developed in the 1930s by a Mexican military doctor. His son of the same name and, for decades now, his grandson Dr. Donato Garcia Perez have made insulin-potentiated therapy known throughout the world and are training doctors in the international IPT Academy.
Dr. Henning Saupe – Medical Director of Arcadia Praxisklinik – is a certified IPT physician and member of the International Academy for IPT<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n

Insulin-potentiated therapy: For fewer side effects in cancer therapy<\/h3>\n\n\n\n

Insulin-potentiated therapy can help to treat a progressive cancer with fewer side effects and thus maintain or improve the patient’s quality of life. Doctors experienced in IPT have also observed that in most cases better results can be achieved with IPT than with normal-dose chemotherapy. Despite the reduced dose, the specific effect seems to be better.<\/p>\n<\/div><\/div>\n\n\n\n

\n

IPT treatment at Arcadia Praxisklinik<\/h2>\n\n\n\n

Insulin-potentiated therapy (IPT) is used at Arcadia Praxisklinik specifically for the treatment of cancer, but also for other chronic diseases. We offer two types of IPT treatment in our practice clinic: The combination of low-dose “classical” chemotherapy in combination with biological anticancer agents in infusion form or only biological anticancer infusions. Which therapy is suitable for you, we recommend on the basis of a detailed examination and diagnosis.<\/p>\n<\/div><\/div>\n\n\n\n

\n